Skip to main content

Exkivity Support Group

Summary

Our support group for Exkivity has 2 questions and 3 members. Updated 5 May 2022.

Latest questions

Further information

Related condition support groups

Non-Small Cell Lung Cancer

Exkivity Patient information at Drugs.com

Latest news

FDA Approves Exkivity (mobocertinib) for EGFR Exon20 Insertion+ Non-Small Cell Lung Cancer (NSCLC)

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE) September 15, 2021 --Takeda Pharmaceutical Company Limited…

Ask a question

To post your own question to our community, sign in or create an account.